Results 51 to 60 of about 30,141 (201)
Frontotemporal demantia and psychiatric symptoms [PDF]
Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2011 Frontotemporal dementia (FTD) is the second most common cause of early onset dementia and is clinically characterized by progressive behavioural change, executive dysfunctions, and language difficulties.Pınar Dikmen Yalınay, Elif Onurdoaj Accuracies (%) of hippocampal volumetry in the following comparisons C vs. PMCI, C vs. AD, PMCI vs. FTD, SMCI vs. FTD, AD vs. FTD and C vs. FTD.
, 2013 Accuracies (%) of hippocampal volumetry in the following comparisons C vs. PMCI, C vs. AD, PMCI vs. FTD, SMCI vs. FTD, AD vs. FTD and C vs. FTD.Miia Kivipelto (293118), Yawu Liu (284161), Miguel Ángel Muñoz-Ruiz (293116), Päivi Hartikainen (293117), Juha Koikkalainen (201083), Robin Wolz (201080), Eini Niskanen (201087), Sanna-Kaisa Herukka (120810), Jyrki Lötjönen (201097), Daniel Rueckert (171282), Ritva Vanninen (293119), Valtteri Julkunen (201082), Hilkka Soininen (120808) +12 morecore +1 more sourceAll in the Family: Repeats and ALS/FTD [PDF]
Trends in Neurosciences, 2018 In 2011, an intronic (G4C2)•(G2C4) expansion was shown to cause the most common forms of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This discovery linked ALS with a clinically distinct form of dementia and a larger group of microsatellite repeat diseases, and catalyzed basic and translational research.Amrutha, Pattamatta, John D, Cleary, Laura P W, Ranum +2 moreopenaire +2 more sourcesDownregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: A GENFI study
, 2018 Objective To determine whether exosomal microRNAs (miRNAs) in cerebrospinal fluid (CSF) of patients with frontotemporal dementia (FTD) can serve as diagnostic biomarkers, we assessed miRNA expression in the Genetic Frontotemporal Dementia Initiative ...Galimberti D, Miller BL, Rohrer JD, Laforce R Jr, Schneider R, Rosen H, Genetic FTD Initiative (GENFI)., Masellis M, Graff C, Kim T, Karydas A, Zhang Z, van Swieten JC, Boxer A, Robertson J, Borroni B, Tartaglia MC, McKeever P, Zinman L +18 morecore +1 more sourceCerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Alzheimer’s Research & Therapy, 2018 Background Reliable biomarkers of frontotemporal dementia (FTD) are currently lacking. FTD may be associated with chronic immune dysfunction, microglial activation and raised inflammatory markers, particularly in progranulin (GRN) mutation carriers ...Ione O. C. Woollacott, Jennifer M. Nicholas, Amanda Heslegrave, Carolin Heller, Martha S. Foiani, Katrina M. Dick, Lucy L. Russell, Ross W. Paterson, Ashvini Keshavan, Nick C. Fox, Jason D. Warren, Jonathan M. Schott, Henrik Zetterberg, Jonathan D. Rohrer +13 moredoaj +1 more sourceModifiable potential risk factors in familial and sporadic frontotemporal dementia
Annals of Clinical and Translational Neurology, 2022 Objective Only a few studies have evaluated modifiable risk factors for frontotemporal dementia (FTD). Here, we evaluated several modifiable factors and their association with disease phenotype, genotype, and prognosis in a large study population ...Helmi Soppela, Kasper Katisko, Yasmine Gadola, Johanna Krüger, Päivi Hartikainen, Antonella Alberici, Alberto Benussi, Anne Koivisto, Annakaisa Haapasalo, Anne M Remes, Barbara Borroni, Eino Solje +11 moredoaj +1 more sourceThe CBI-R detects early behavioural impairment in genetic frontotemporal dementia [PDF]
, 2022 Supporting Information available at: https://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Facn3.51544&file=acn351544-sup-0001-supinfo.docx (Word 2007 document, 330.8 KB).Copyright © 2022 The Authors.Funkiewiez, A, Heller, C, Bocchetta, M, Castelo-Branco, M, Giaccone, G, Karnath, HO, Bender, B, Miltenberger, G, Colliot, O, Jelic, V, Bras, J, Arighi, A, Rohrer, JD, Benussi, A, Santana, I, de Arriba, M, Indakoetxea, B, Lombardi, G, Levin, J, Brice, A, Kuchcinski, G, Masellis, M, Caroppo, P, Synofzik, M, Afonso, S, Bertrand, A, Cope, T, Borroni, B, Antonell, A, van Minkelen, R, Convery, RS, Cash, D, Tartaglia, MC, Archetti, S, Borrego-Ecija, S, Laforce, R, Russell, LL, Fumagalli, G, Galimberti, D, Nelson, A, Gabilondo, A, Peakman, G, Meeter, L, Bertoux, M, Bouzigues, A, Bessi, V, Black, S, Barandiaran, M, Loosli, S, van Swieten, JC, Gazzina, S, Leitão, MJ, Otto, M, Fox, N, Di Fede, G, Maruta, C, Greaves, CV, Bargalló, N, Jiskoot, L, Genetic FTD Initiative (GENFI), Hoegen, T, Ducharme, S, Sanchez-Valle, R, Guerreiro, R, Freedman, M, Cantoni, V, Balasa, M, Duro, D, Gasparotti, R, Finger, E, Fenoglio, C, Deramecourt, V, Ferreira, CB, Díez, A, Almeida, MR, Mead, S, Rowe, JB, Le Ber, I, Bruffaerts, R, Andersson, C, Cañada, M, Moreno, F, Ferrari, C, Keren, R, Lladó, A, Bartha, R, Graff, C, Greaves, C, Camuzat, A, Gorostidi, A, Cash, DM, Butler, CR, Gerhard, A, Langheinrich, T, Vandenberghe, R, Lebouvier, T, de Mendonça, A, Sorbi, S, Gauthier, S, Pasquier, F, Anderl-Straub, S +100 morecore +1 more sourceNeuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales.
, 2023 BACKGROUND: Current clinical rating scales in frontotemporal dementia (FTD) often do not incorporate neuropsychiatric features and may therefore inadequately measure disease stage.Masellis, Mario, Matthis Synofzik, Bocchetta, M, Simon Ducharme, Jiskoot, Lize C., Peakman, Georgia, Caroline Graff, Galimberti, Daniela, Kiran Samra, Finger, Elizabeth, Rohrer, JD, Rik Vandenberghe, Cash, David M., Levin, Johannes, Santana, I, Harro Seelaar, Otto, Markus, Samra, Kiran, Levin, J, Masellis, M, Rohrer, Jonathan D., Synofzik, M, Isabel Santana, Sandro Sorbi, James B Rowe, Vandenberghe, Rik, Lize C Jiskoot, Borroni, B, Seelaar, H, Arabella Bouzigues, Santana, Isabel, Convery, RS, Macdougall, Amy, Russell, Lucy L., Greaves, Caroline V., Greaves, Caroline, Tartaglia, MC, Synofzik, Matthis, Jiskoot, Lize C.; id_orcid, Laforce, R, David M Cash, Robert Laforce, Convery, Rhian S, Raquel Sánchez-Valle, Fermin Moreno, Ducharme, Simon, Jiskoot, LC, Markus Otto, Russell, LL, Galimberti, D, Peakman, G, Bruffaerts, Rose, Borroni, Barbara, Bouzigues, A, Genetic FTDInitiative (GENFI), Barbara Borroni, Martina Bocchetta, Rademakers, Rosa, van Swieten, JC, Butler, Christopher R., Alexander Gerhard, Sánchez-Valle, Raquel, Isabelle Le Ber, Gerhard, Alexander, Bouzigues, Arabella, Otto, M, Convery, Rhian S., Le Ber, Isabelle, Caroline V Greaves, Greaves, CV, Genetic FTD Initiative (GENFI), Ducharme, S, Moreno, Fermin, Butler, Christopher R, Sorbi, Sandro, Macdougall, A, van Swieten, John C, Rowe, James B., S\ue1nchez-Valle, Raquel, Tiraboschi, Pietro, Finger, E, Alexandre de Mendonca, Russell, Lucy L, de Mendonca, A, Christopher R Butler, Rowe, James B, Johannes Levin, Rowe, JB, Le Ber, I, Graff, Caroline, Rhian S Convery, Moreno, F, Daniela Galimberti, Bocchetta, Martina, Georgia Peakman, Seelaar, Harro, Mario Masellis, Tartaglia, Maria Carmela, Greaves, Caroline V, Amy Macdougall, Laforce, Robert, Graff, C, Florence Pasquier, Samra, K, Tiraboschi, P, Elizabeth Finger, Sánchez-Valle, R, John C van Swieten, Pasquier, Florence, Cash, DM, Butler, CR, Gerhard, A, Cash, David M, Rohrer, Jonathan D, Vandenberghe, R, Jiskoot, Lize C, de Mendonca, Alexandre, Sorbi, S, Pietro Tiraboschi, van Swieten, John C., Lucy L Russell, Maria Carmela Tartaglia, Pasquier, F, Jonathan D Rohrer +123 morecore +2 more sources
